Vaccinology, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
PLoS One. 2013;8(1):e54314. doi: 10.1371/journal.pone.0054314. Epub 2013 Jan 23.
Outer membrane vesicles (OMV) contain immunogenic proteins and contribute to in vivo survival and virulence of bacterial pathogens. The first OMV vaccines successfully stopped Neisseria meningitidis serogroup B outbreaks but required detergent-extraction for endotoxin removal. Current vaccines use attenuated endotoxin, to preserve immunological properties and allow a detergent-free process. The preferred process is based on spontaneously released OMV (sOMV), which are most similar to in vivo vesicles and easier to purify. The release mechanism however is poorly understood resulting in low yield. This study with N. meningitidis demonstrates that an external stimulus, cysteine depletion, can trigger growth arrest and sOMV release in sufficient quantities for vaccine production (±1500 human doses per liter cultivation). Transcriptome analysis suggests that cysteine depletion impairs iron-sulfur protein assembly and causes oxidative stress. Involvement of oxidative stress is confirmed by showing that addition of reactive oxygen species during cysteine-rich growth also triggers vesiculation. The sOMV in this study are similar to vesicles from natural infection, therefore cysteine-dependent vesiculation is likely to be relevant for the in vivo pathogenesis of N. meningitidis.
外膜囊泡(OMV)含有免疫原性蛋白,有助于细菌病原体在体内的存活和毒力。第一批 OMV 疫苗成功阻止了脑膜炎奈瑟菌 B 群的爆发,但需要去污剂提取去除内毒素。目前的疫苗使用减毒内毒素,以保留免疫原性,并允许无去污剂处理。首选的方法是基于自发释放的 OMV(sOMV),其与体内囊泡最相似,并且更容易纯化。然而,释放机制了解甚少,导致产量低。本研究表明,脑膜炎奈瑟菌在外部刺激、半胱氨酸耗尽的情况下,可以触发生长停滞和足够数量的 sOMV 释放,用于疫苗生产(每升培养物可生产±1500 剂人类剂量)。转录组分析表明,半胱氨酸耗尽会损害铁硫蛋白的组装,并导致氧化应激。通过表明在富含半胱氨酸的生长过程中添加活性氧也会触发囊泡化,证实了氧化应激的参与。本研究中的 sOMV 与天然感染的囊泡相似,因此半胱氨酸依赖性囊泡化可能与脑膜炎奈瑟菌的体内发病机制相关。